Is Broadcom Stock a Millionaire Maker?
Broadcom (Nasdaq: AVGO) stock has gone up more than 64%…
Sell
27
APLS Quote, Financials, Valuation and Earnings
Last price:
$19.12
Seasonality move
:
-4.11%
Day range:
$18.99 - $20.18
52-week range:
$16.98 - $47.60
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
3.03x
P/B ratio:
10.50x
Volume:
4.3M
Avg. volume:
2.7M
1-year change:
-60.83%
Market cap:
$2.4B
Revenue:
$781.4M
EPS (TTM):
-$1.59
APLS Analysts' Consensus Rating
The 19 analysts providing 12-month price projections for Apellis Pharmaceuticals shares anticipate an average target of $41.50, ranging from a low estimate of $21.00 to a high estimate of $75.00. This average target implies a growth of 117.05% compared to the current stock price of $19.12.
Consensus Price Target
$41.50
Highest Price Target
$75.00
Lowest Price Target
$21.00
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Analyst Ratings
| 6M Ago | 1M Ago | Current | |
|---|---|---|---|
| Buy | 11 | 11 | 11 |
| Hold | 7 | 8 | 8 |
| Sell | 0 | 0 | 0 |
| Consensus | Buy | Buy | Buy |
APLS Recommendation Trends
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Berkshire The Best Stock to Buy in a Bad Market?
Berkshire Hathaway (NYSE:BRK.A, BRK.B) has historically been one of the…
Is Shopify Stock Still a Buy in 2025 or Has Growth Peaked?
The big picture trends in e‑commerce sales are clearly in…
Stock Ideas
Buy
70
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
60
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 39x
Alerts
Buy
60
RGC alert for May 7
Regencell Bioscience Holdings [RGC] is up 73.72% over the past day.
Buy
77
FARO alert for May 7
Faro Technologies [FARO] is up 34.66% over the past day.
Buy
63
SKX alert for May 7
Skechers USA [SKX] is down 0.07% over the past day.
